Purgatory said...
C-Diff is bad news. They have had several out breaks at the long care and PT center my wife works at. I am terrified of her bring this home with her, after her contact with infected patients. MYRSA is very common too there.
Another thing I am often perplexed that doctor's don't routinely warn about
: the increased risk of C-diff (plus other SEs) for anyone taking various stomach acid reducing drugs, particularly proton pump inhibitors.
www.ncbi.nlm.nih.gov/pubmed/27021503Somebody said...
Abstract
Background/Aims:
Proton pump inhibitors (PPIs) and histamine-2 receptor antagonists (H2RAs) are commonly prescribed for stress ulcer prophylaxis (SUP) in critically ill patients. Several studies have suggested that the use of PPIs is a potential risk factor for Clostridium difficile infection (CDI). We compared the incidences of CDI in the PPI group and H2RA group for SUP in critically ill patients.
Methods:
From August 2005 to July 2012, the incidences of CDI were retrospectively analyzed in patients who were admitted directly to intensive care units and stayed for more than 3 days. SUP-related CDI was defined as a CDI diagnosed during the SUP period. Patient clinical data were analyzed to identify potential risk factors for SUP-related CDI.
Results:
Of the 1,005 patients enrolled (444 patients received PPI and 561 received H2RA), 38 (3.8%) were diagnosed with SUP-related CDI.
The incidence of SUP-related CDI was considerably higher in patients who received PPI than in those who received H2RA (6.7% vs 1.8%). PPI use for SUP (odds ratio [OR], 3.3; confidence interval [CI], 1.5 to 7.1; p=0.003) and diabetes mellitus (OR, 2.3; CI, 1.2 to 4.7; p=0.019) were independent risk factors for SUP-related CDI.
Conclusions:
PPI therapy is associated with a higher risk of SUP-related CDI than H2RA therapy in critically ill patients.
www.ncbi.nlm.nih.gov/pubmed/25540023Somebody said...
long PPI exposure (odds ratio (OR) (95% confidence interval (CI) = 2.03 (1.23 to 3.36), P = 0.006) and antibiotic use (OR (95% CI) = 2.52 (1.23 to 5.18), P = 0.012) were identified as independent predictors of CDI.
CONCLUSIONS:
Proton pump inhibitors are independent risk factors for the development of CDI in ICU patients. This risk is particularly exposed after two or more days of therapy.
After 2 days! How many are on permanent Tagamet or Prilosec?
Keep in mind that in the above studies indicating the proton pump inhibitors(such as Prilosec) are worse than the the histamine-2 receptor antagonists such as Tagamet, still even the less potent drugs can put you at risk for C-Diff and other SEs:
www.ncbi.nlm.nih.gov/pubmed/20458086Somebody said...
METHODS:
We conducted a pharmacoepidemiologic cohort study, performing a secondary analysis of data collected prospectively on 101 796 discharges from a tertiary care medical center during a 5-year period. The primary exposure of interest was acid suppression therapy, classified by the most intense acid suppression therapy received (no acid suppression, histamine(2)-receptor antagonist [H(2)RA] therapy, daily proton pump inhibitor [PPI], and PPI more frequently than daily).
RESULTS:As the level of acid suppression increased, the risk of nosocomial C difficile infection increased..........................After adjustment for comorbid conditions, age, antibiotics, and propensity score-based likelihood of receipt of acid-suppression therapy, the association persisted, increasing from an odds ratio of 1 (no acid suppression [reference]) to 1.53 (95% CI, 1.12-2.10) (H(2)RA), to 1.74 (95% CI, 1.39-2.18) (daily PPI), and to 2.36 (95% CI, 1.79-3.11) (more frequent PPI). Similar estimates were found with a matched cohort analysis and with nested case-control techniques.
CONCLUSIONS:
Increasing levels of pharmacologic acid suppression are associated with increased risks of nosocomial C difficile infection. This evidence of a dose-response effect provides further support for the potentially causal nature of iatrogenic acid suppression in the development of nosocomial C difficile infection.
Post Edited (BillyBob@388) : 4/23/2016 10:32:40 AM (GMT-6)